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INTRODUCTION 
The prevalence of type 2 diabetes has increased dramatically over the past three decades and current 
estimates predict a further 50% increase worldwide by the year 2030.1 Diabetes is associated with      
numerous micro- and macrovascular complications including, blindness, kidney failure and limb           
amputation.2 Furthermore, the presence of diabetes increases the risk of cardiovascular disease (CVD) 
two to five fold, especially for women.3,4 Alongside the current global obesity epidemic5,6, the increase 
in prevalence of diabetes is going to further strain the already-overburdened healthcare system of United 
States and potentially prove catastrophic for nations with limited resources. 
While there is no available cure for diabetes, studies have shown that primary prevention can be  
attained through modifications to diet and lifestyle. Unfortunately, with mass media as a vehicle, the 
general public, for the most part, has been exposed to “fad diets” and “magic bullets” that not only lead 
to no metabolic benefits but may in fact, in some circumstances, prove harmful by depriving the body of 
many essential nutrients. These “quick-to-fix” approaches have drawn the attention away from the     
traditional staples of human diet such as whole grains, fruit, green leafy vegetable, seeds and nuts which 
have been linked by scientific evidence to a reduced risk of a number of chronic diseases including    
diabetes and CVD.7 The purpose of this paper is to 1) provide a brief overview of the current evidence 
linking tree nuts to the risk of diabetes and heart disease and 2) to outline some of the key challenges for 
recommending nuts as part of a healthy diet to patients with or at risk of diabetes or heart disease. 
TREE NUTS 
The term, “nut”, encompasses a wide range of 
seeds that based strictly on botanical definitions are 
not actually nuts. While hazelnuts meet the botanical 
definition, almonds, pistachios and walnuts which are 
all seeds of drupe fruits, do not. Despite this            
inconsistency, the aforementioned seeds, along with 
hazelnuts, pine nuts, pecans, cashews, Brazils, and 
macadamias have been clustered together under the 
collective term, “tree nuts” by the International Tree 
Nut Council.8 
Until recently, in Western societies, nuts were  
considered to be high fat and as such, contraindicated 
in therapeutic diets. However, scientific evidence in 
the past decade has changed this negative perception. 
Despite small variations in their micro- and        mac-
ronutrient profiles, tree nuts as a whole are healthy 
foods because of their favorable fatty acid profile (low 
in saturated fats and high in mono- and polyunsaturated fats [MUFAs and PUFAs respectively]). They 
are also low in available carbohydrate content, as well as being good sources of vegetable protein, fiber, 
phytosterols, polyphenols, vitamins and minerals. Table 1 summarizes the micro- and macronutrient  
profile of some commonly consumed nuts. Nuts may therefore be a useful component of a dietary strate-
gy aimed improving the risk factors of diabetes and CVD. 
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Table 1 Nutritional profile of commonly consumed, whole, natural nuts (per ounce) 
Modified from tables prepared by the International Tree Nut Council8, accessed on January 15, 2011. The values 
are for unsalted, unroasted nuts (except for cashews and pistachios which were dry roasted)*mg (miligram); %DV 
= % daily value 
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  Almonds Cashews Pecans Pistachios Walnuts 
Number of Kernels per Ounce 23 18 19 halves 49 14 halves 
Total Energy, kcal 160 160 200 160 190 
Protein, g 6 4 3 6 4 
Carbohydrates, by difference, g 6 9 4 8 4 
     Fiber, total dietary, g 4 1 3 3 2 
Total Lipids 14 13 20 13 18 
     Saturated fatty acids, g 1 3 2 1.5 1.5 
     Monounsaturated fatty acids, g 9 8 12 7 2.5 
     Polyunsaturated fatty acids, g 3.5 2 6 4 13 
Cholesterol 0 0 0 0 0 
Minerals, mg* (% DV)           
     Calcium 75 (8) 13(0) 20(2) 31 (3) 28 (2) 
     Iron 1.1 (6) 1.7 (10) 0.7 (4) 1.2 (6) 0.8 (4) 
     Sodium 0 (0) 5 (0) 0 (0) 3 (0) 1 (0) 
     Potassium 200 (6) 160 (4) 116 (4) 295 (9) 125 (4) 
     Magnesium 76 (20) 74 (20) 34 (8) 34 (8) 45 (10) 
     Phosphorus 137 (15) 139 (15) 79 (8) 137 (15) 98 (10) 
     Zinc 0.9 (6) 1.6 (10) 1.3 (8) 0.6 (4) 0.9 (6) 
     Manganese 0.7 (30) 0.2 (10) 1.3 (60) 0.4 (20) 1.0 (50) 
     Copper 0.2 (15) 0.6 (30) 0.3 (15) 0.4 (20) 0.5 (25) 
     Selenium, mcg 0.7 (0) 3.3 (4) 1.1 (2) 2.6 (4) 1.4 (2) 
Vitamins, mg* (% DV)           
     Thiamin 0.06 (4) 0.06 (4) 0.19 (10) 0.24 (15) 0.1 (6) 
     Riboflavin 0.3 (15) 0.06 (4) 0.04 (2) 0.05 (2) 0.04 (2) 
     Niacin 1.0 (4) 0.4 (2) 0.3 (2) 0.4 (2) 0.3 (2) 
     Vitamin B-6, Ƭg 0.04 (2) 0.07 (4) 0.06 (2) 0.36 (20) 0.15 (8) 
     Folate, total, Ƭg 14 (4) 20 (4) 6 (2) 14 (4) 28 (6) 
     Vitamin E (total tocopherols) (35) (0) (2) (2) (0) 
NUTS & HEART DISEASE 
The protective effect of nuts in relation to the risk of CVD has been demonstrated in a number of 
cohort studies. A pooled-analysis of the results from four major cohorts9-12 (sample size of over 170,000 
individuals) demonstrated that in comparison to little or no nut consumption, the highest intake group 
for nut consumption (4 or more servings per week) had a statistically significant reduction of             
approximately 35% in the risk of developing coronary heart disease (CHD).13 
Clinical interventions have supported the findings of the aforementioned cohort studies and have 
shed light on potential mechanisms of action. The dietary interventional studies have shown that nut 
consumption can reduce the risk of heart disease by improving serum lipid profile, endothelial function, 
and blood pressure, in addition to lowering oxidative stress, and inflammation.14 Two systematic       
reviews showed that the intake of 1.5 to 3.5 ounces of nuts, 5 or more times per week, can reduce LDL-
cholesterol (LDL-C) 3-19% in comparison to Western or lower fat diets.15,16 Meta-analyses of clinical 
trials involving almonds or walnuts have demonstrated that both are effective in significantly lowering 
Total-C and LDL-C.17,18 Furthermore, despite the absence of a pooled analysis, the results from 4    clin-
ical trials show that the intake of 2 to 3.5 ounces (approximately 50 kernels/oz) of pistachios per day 
increased serum HDL-C levels.19-22 The strength of the evidence has prompted the United States Food 
and Drug Agency (USFDA) to approve a qualified health claim for nuts and serum cholesterol           
reduction. 
NUTS AND TYPE 2 DIABETES     
While the current evidence demonstrates that the frequent intake of nuts is protective against heart 
disease, the effect of nuts on the risk of developing type 2 diabetes is not as conclusive. Of the two    
cohort studies on this topic, one showed a 27% reduction in the relative risk of developing diabetes in 
individuals who consumed nuts five or more times per week compared with those who rarely or never 
ate nuts23, while the other did not show a link between nut/peanut intake and the risk of type 2            
diabetes.24 
Despite the inconsistency in the epidemiological evidence, there are a number of plausible      mech-
anisms that suggest a potential protective effect for nuts against the risk of type 2 diabetes. The first re-
lates to the low available carbohydrate content of nuts (Table 1). Adequate glycemic control is crucial 
for prevention and management of type 2 diabetes.25 A number of acute studies have shown that al-
monds are capable of improving post-meal glyciemic control through low post-meal glucose and    insu-
lin responses.26, 27 Both of these parameters have been linked to improved insulin sensitivity, prevention 
of hyperinsulinemia and overall, improved glycemic control in patients with type 2 diabetes.28   Howev-
er, despite plausible evidence it is not clear if improvements in acute glycemia are indicative of long 
term changes in insulin resistance. Moreover, the limited number of long-term clinical trials in this area 
have been inconclusive, with some showing benefits in fasting insulin and glucose and others    showing 
no effect.29 Worth noting is that no study to date has shown improvements in HbA1c (established marker 
of long-term glycemic control). However, these long-term term trials have had a number of limitations, 
which have been outlined in other publications.14 
Several other lesser studied mechanisms for reducing the risk of diabetes include: reduction in in-
flammation30, which has been linked to the risk of diabetes and heart disease31, or improvement in     
glycemic control through displacement of carbohydrates with MUFAs (high in nuts)32. Finally, a recent 
meta-analysis of the prospective studies showed that a 100mg per day increase in dietary magnesium 
intake reduced the risk of developing diabetes by 14%.33 Nuts are good sources of magnesium (Table 1). 
 
Amin Esfahani: Tree Nuts & Disease Prevention 
11 
The current body of scientific research demonstrates that nuts may have a modest beneficial effect 
on serum lipids and markers of glycemia in subjects with type 2 diabetes.14, 34 Therefore, the moderate 
use of nuts as a part of a healthy diet and in very high risk populations alongside medication may help 
better manage diabetes. Furthermore, while the assessment of long-term effect of nuts in prevention and 
management of diabetes is required, due to the potentially favourable effects on glycemia and            
inflammation intake of nuts may benefit those at risk of developing diabetes. 
KEY CHALLENGES 
There are a number of concerns associated with recommending the intake of nuts to high risk    pop-
ulations (e.g. patients with diabetes). Food allergy is one of these concerns. Currently, 0.4% of the US 
population are allergic to tree nuts (most prevalent allergies are those to walnuts, cashews and       al-
monds).35 This type of allergy is a major contributor to the overall 100-200 annual deaths that result 
from food-induced anaphylaxis.36 
There are also several important research areas that need to be addressed when assessing the impact 
of nuts on health outcomes. One is the aforementioned, long term effect on markers of diabetes. Another 
has to do with the fact that despite similarities, there are still differences in micro- and macronutrient 
profiles of specific nuts, which may lead to different metabolic effects. Therefore, more trials need to be 
conducted using the “lesser-studied” tree nuts in order to determine whether they generate comparable 
metabolic benefits to almonds, walnuts and pistachios (the “more studied” tree nuts). Furthermore, the 
efficacy of mixed-nut diets should also be examined. Finally, dose-response studies should be           
conducted, in order to determine the ideal intake levels for maximal metabolic benefits and to also      
establish detrimental doses. 
The most common cited concerns with nut consumption are their high fat content and energy      
density, which some fear will lead to weight gain and consequently, obesity. However, the overall     
evidence from epidemiological studies not only shows no association between nut intake and weight 
gain, but it in fact points to an inverse trend.37 Furthermore, evidence suggests that in the context of   
energy-restricted diets, the addition of nuts generates a more lasting and greater magnitude of weight 
loss among obese subjects.38  One mechanism of action that has been studied in almonds, suggests that 
the cell walls of almonds decrease the bioaccessibility of lipids by hindering their availability for       
digestion.39  However, more clinical trials are required to assess the impact of nuts on weight loss and if 
applicable, to help determine the potential mechanisms of action. Overall, addressing these key        
challenges will allow governing agencies to make better recommendations to the general public. 
CONCLUSION 
Tree nuts on their own are not “magic bullets” that will prevent chronic diseases. However, the   
current body of scientific evidence shows that their addition to healthy diets leads to additional        met-
abolic benefits. For instance, the addition of nuts to a vegan-diet rich in plant sterols, vegetable    pro-
teins and soluble fiber led to reductions in LDL-C similar to those obtained with starting doses of Statin 
medication.40 Furthermore, their inclusion in the Mediterranean or weight loss diets has improved the 
efficacy of these diets in comparison to the currently recommended therapeutic diets.41-43 Overall, the 
intake of nuts as part of a healthy diet can improve risk factors of heart disease, short-term glycemic 
control and to a limited extent enhance weight loss. As such, in lieu of their energy density, healthy   
individuals and those at high risk of type 2 diabetes and/or heart disease will benefit from the inclusion 
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